BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2848156)

  • 1. Glucagonoma presenting as morbid obesity.
    Martin FM; Hamilton W; Dons R; Cashell AW; Ghosh BC
    J Surg Oncol; 1988 Dec; 39(4):256-9. PubMed ID: 2848156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
    Skouge JW; Farmer ER
    Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
    van der Loos TL; Lambrecht ER; Lambers JC
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
    Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pancreatic tumor with diabetes and necrotic migratory erythema. Glucagonoma or proglucagonoma?].
    Gillet M; Rodier C; Quencez E; Laurent R; Mantion G; Landecy G; Nguyen N; Carbillet JP
    Chirurgie; 1988; 114(5):441-6. PubMed ID: 2852092
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructural studies of necrolytic migratory erythema.
    Ohyama K; Kitoh M; Arao T
    Arch Dermatol; 1982 Sep; 118(9):679-82. PubMed ID: 6287944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migratory erythema and glucagonoma: descriptive nomenclature.
    Burgdorf WH
    Ann Intern Med; 1988 Jun; 108(6):912-3. PubMed ID: 2835921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 14. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucagonoma syndrome.
    Shupack JL; Berczeller PH; Stevens DM
    J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucagonoma syndrome].
    Picard C; Mazer JM; Bilet S; Villette B; Penchet A; Toublanc M; Grossin M; Debussche X; Assan R; Belaïch S
    Ann Dermatol Venereol; 1988; 115(11):1142-5. PubMed ID: 2853600
    [No Abstract]   [Full Text] [Related]  

  • 19. A recurrent intertriginous rash responsive to topical as well as surgical therapy. Necrolytic migratory erythema with saprophytic superinfection.
    Dons RF; Cashell AW
    Arch Dermatol; 1988 Mar; 124(3):431, 434. PubMed ID: 2830850
    [No Abstract]   [Full Text] [Related]  

  • 20. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
    Chang CH; Sheu HM; Cheng GS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.